 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nordea Investment Management AB raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO  Free Report) by 407.0% during the second quarter, according to the company in its most...

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Nordea Investment Management AB

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Tko Group Holdings Inc Class A (TKO) was identified as having a larger market cap than the smaller end of...

Tko Group Holdings Larger Than S&amp;P 500 Component Bio-Rad Laboratories

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Darling Ingredients Inc (DAR) was identified as having a larger market cap than the smaller end of the...

Darling Ingredients Larger Than S&amp;P 500 Component Bio-Rad Laboratories

Investors considering a purchase of Bio-Rad Laboratories Inc (BIO) stock, but tentative about paying the going market price of 371.10/share, might benefit from considering selling puts among the...

Commit To Purchase Bio-Rad Laboratories At $360, Earn 17.6% Annualized Using Options

A deep dive into the intrinsic value of Bio-Rad Laboratories, shedding light on its current market value.Related Stocks: BIO...

Unveiling Bio-Rad Laboratories (BIO)'s Value: Is It Really Priced Right? A Comprehensive Guide

Bio-Rad Laboratories, Inc. (NYSE:BIO  Free Report)  Investment analysts at Zacks Research lowered their Q3 2023 earnings estimates for Bio-Rad Laboratories in a research note issued...

Zacks Research Weighs in on Bio-Rad Laboratories, Inc.'s Q3 2023 Earnings (NYSE:BIO)

Element Capital Management LLC purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO  Free Report) during the first quarter, according to its most recent 13F filing with the...

Element Capital Management LLC Invests $1.26 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)

Bio-Rad Laboratories, Inc. (NYSE:BIO  Get Free Report) EVP Timothy S. Ernst sold 2,350 shares of the stock in a transaction on Wednesday, August 30th. The shares were sold at an average price...

Insider Selling: Bio-Rad Laboratories, Inc. (NYSE:BIO) EVP Sells 2,350 Shares of Stock

RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories (BIO Research Report) on August 27 and set a price target of $... RBC Capital analyst Conor McNamara maintained a Buy rating on Bio-Rad Laboratories (BIO  Research...

Bio-Rad Laboratories (BIO) Receives a Buy from RBC Capital

Vinva Investment Management Ltd bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO  Free Report) during the 1st quarter, according to its most recent filing with the...

Vinva Investment Management Ltd Takes $1.23 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Watchers	920
52-Wk Low	$344.63
52-Wk High	$509.62

Market Cap	$10.39B
Volume (M)	104,276.00
52-Wk High	$509.62
52-Wk Low	$344.63

BIO Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals